Bancel v. Bernie, Sarepta’s FDA runaround, & Regeneron’s ever-growing blockbuster

Do you miss Adam as much as we do?

March 24, 2023 Check out STAT+

Sponsored By

What would Jonas Salk say if he were here right now? How do you know when an ALS treatment is working? And what can pharma CEOs learn from Mr. Rogers? We cover all that and more this week on the 251st episode of "The Readout LOUD," STAT's biotech podcast. We discuss the theatrical merits and actual implications of Moderna CEO Stéphane Bancel's appearance before a committee led by Sen. Bernie Sanders. We also talk about the latest news in the life sciences, including Regeneron Pharmaceuticals' latest data for its powerhouse drug Dupixent, an about-face for Sarepta Therapeutics, and how the FDA appears to view biomarkers in neurological diseases. Listen Now And we're now on YouTube!  Check it out. Subscribe to the podcast to never miss an episode iTunes Spotify SoundCloud Stitcher TuneIn Visit the archive to see past episodes

---

---

Enjoying The Readout LOUD? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2023, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser